Cargando…

Rare tumours of the breast

Detalles Bibliográficos
Autores principales:	Esposito, Emanuela, De Laurentiis, Michelino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798354/ https://www.ncbi.nlm.nih.gov/pubmed/35117120 http://dx.doi.org/10.21037/tcr.2019.10.05

Ejemplares similares

The role of taxanes in triple-negative breast cancer: literature review
por: Mustacchi, Giorgio, et al.
Publicado: (2015)

Male Breast Cancer: From Molecular Genetics to Clinical Management
por: Pensabene, Matilde, et al.
Publicado: (2022)

How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer
por: Untch, Michael, et al.
Publicado: (2021)

Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report
por: Caputo, Roberta, et al.
Publicado: (2023)

Long Non-Coding RNA HOTAIR in Breast Cancer Therapy
por: Cantile, Monica, et al.
Publicado: (2020)

Experience with intraoperative radiotherapy for breast cancer: the Geneva University Hospital’s experience
por: Esposito, Emanuela, et al.
Publicado: (2016)

Rare rib tumours: Where geography matters
por: Schewitz, I
Publicado: (2022)

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series
por: Crispo, Anna, et al.
Publicado: (2013)

Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype
por: Capasso, Immacolata, et al.
Publicado: (2014)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2015)

Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology
por: Amirkhani Namagerdi, Asadoor, et al.
Publicado: (2020)

A Rare Tumour of the Breast: Carcinosarcoma
por: Ilhan, Enver, et al.
Publicado: (2010)

LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2019)

Targeting Autophagy in Breast Cancer
por: Cocco, Stefania, et al.
Publicado: (2020)

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
por: Cocco, Stefania, et al.
Publicado: (2020)

Rolling out radioguided occult lesion localisation for breast tumours
por: Chung, David K V
Publicado: (2015)

Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
por: Piezzo, Michela, et al.
Publicado: (2020)

Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial
por: Capasso, Immacolata, et al.
Publicado: (2013)

A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life
por: Chirico, Andrea, et al.
Publicado: (2017)

Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
por: Adamo, Vincenzo, et al.
Publicado: (2022)

The Synovium Theory: Can Exercise Prevent Knee Osteoarthritis? The Role of “Mechanokines”, A Possible Biological Key
por: Di Rosa, Michelino, et al.
Publicado: (2019)

Breast cancers are rare diseases—and must be treated as such
por: Bartlett, John M. S., et al.
Publicado: (2017)

Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells
por: Ambrosio, Maria Rosaria, et al.
Publicado: (2017)

NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells
por: Quagliariello, Vincenzo, et al.
Publicado: (2020)

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
por: Pelizzari, Giacomo, et al.
Publicado: (2018)

Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?
por: Poggio, Francesca, et al.
Publicado: (2018)

Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study
por: Buono, Giuseppe, et al.
Publicado: (2020)

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients
por: Botti, Gerardo, et al.
Publicado: (2017)

Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5
por: D’Esposito, Vittoria, et al.
Publicado: (2016)

Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
por: D’Arienzo, Andrea, et al.
Publicado: (2023)

Active lifestyles in older adults: an integrated predictive model of physical activity and exercise
por: Galli, Federica, et al.
Publicado: (2018)

Virtual Reality Rehabilitation Systems for Cancer Survivors: A Narrative Review of the Literature
por: Melillo, Antonio, et al.
Publicado: (2022)

Hereditary Tumours
por: Baudi, Francesco
Publicado: (2013)

Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: Subgroup analysis of the phase IIIb CompLEEment-1 trial
por: Cottu, Paul, et al.
Publicado: (2022)

Circulating tumour DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer
por: Abbosh, C, et al.
Publicado: (2018)

Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models
por: Cocco, Stefania, et al.
Publicado: (2022)

Putting Warburg to work: how imaging of tumour acidosis could help predict metastatic potential in breast cancer
por: Rolver, Michala Gylling, et al.
Publicado: (2020)

Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study
por: Gligorov, Joseph, et al.
Publicado: (2022)

The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour
por: de Bree, Remco
Publicado: (2010)

Metaplastic breast carcinoma; melanocytic variant, a very rare tumour
por: Nzegwu, Martin A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_olkg1ugcs6ekmmk1mv5mntkjjb